{"DataElement":{"publicId":"2684636","version":"2","preferredName":"Cancer Identification Multiple Tumor Date","preferredDefinition":"The month, day and year the patient is diagnosed with multiple tumor(s) reported as a single primary using the SEER, IARC, or Canadian Cancer Registry multiple primary rules.","longName":"2684627v1.0:2684638v1.1","context":"PS-CC","contextVersion":"1","DataElementConcept":{"publicId":"2684627","version":"1","preferredName":"Cancer Identification Multiple Tumor","preferredDefinition":"The identification of cases with multiple tumors that are abstracted and reported as a single primary using the SEER, IARC, or Canadian Cancer Registry multiple primary rules.","longName":"2666870v1.0:2684625v1.0","context":"PS-CC","contextVersion":"1","ObjectClass":{"publicId":"2666870","version":"1","preferredName":"Malignant Neoplasm Identified","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:Identified; having the identity known or established.","longName":"C9305:C25737","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identification","conceptCode":"C25737","definition":"The procedure of having an identity established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"36033E9E-8A70-432F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-07-24","modifiedBy":"ONEDATA","dateModified":"2007-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2684625","version":"1","preferredName":"Multiple Neoplasm","preferredDefinition":"many copies of or many forms:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C17648:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple","conceptCode":"C17648","definition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AF89A27-0ED7-05F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-09-25","modifiedBy":"ONEDATA","dateModified":"2007-09-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AF89A27-0EE8-05F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-09-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2684638","version":"1.1","preferredName":"Multiple Neoplasm Date","preferredDefinition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold. (dictionary.com)_An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004_a particular day specified as the time something has, or will, happen.","longName":"2684638v1.0","context":"PS-CC","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"format":"YYYYMMDD","PermissibleValues":[],"ConceptualDomain":{"publicId":"2435030","version":"1","preferredName":"NCI Administrative Concept","preferredDefinition":"Conceptual entities required by NCI operations and systems. Includes administrative, financial, organizational and quasi-scientific concepts required for NCI operations and systems. ","longName":"C28389","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432182-1611-25E9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2684637","version":"1","preferredName":"Multiple Neoplasm Date","preferredDefinition":"many copies of or many forms:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.:a particular day specified as the time something has, or will, happen.","longName":"C17648:C3262:C25164","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple","conceptCode":"C17648","definition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AFA660E-0846-2D7C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-25","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-09-25","modifiedBy":"ONEDATA","dateModified":"2007-09-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB1CE9AE-C9FE-CDE9-E040-BB89AD4301FB","latestVersionIndicator":"Yes","beginDate":"2010-06-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-08-22","modifiedBy":"CURTIST","dateModified":"2011-11-08","changeDescription":"08/22/2011 - tc- Updated display format as per V12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2193114","version":"1","longName":"Division of Cancer Control and Population Sciences","context":"PS-CC","ClassificationSchemeItems":[{"publicId":"3134731","version":"1","longName":"CancerID12.1","context":"PS-CC"},{"publicId":"3134707","version":"1","longName":"NAACCR 12.1","context":"PS-CC"},{"publicId":"5899833","version":"1","longName":"NAACCR 16","context":"PS-CC"},{"publicId":"5899834","version":"1","longName":"CancerID16","context":"PS-CC"},{"publicId":"7464305","version":"1","longName":"NAACCR 18","context":"PS-CC"},{"publicId":"7464307","version":"1","longName":"CancerID18","context":"PS-CC"}]}],"AlternateNames":[{"name":"445","type":"NAACCR Item #","context":"PS-CC"},{"name":"DATE OF MULTIPLE TUMORS","type":"NAACCR Item Name","context":"PS-CC"},{"name":"Date of Mult Tumors","type":"NAACCR Item Name","context":"PS-CC"},{"name":"Date of Multiple Tumors","type":"NAACCR Alt Name","context":"PS-CC"}],"ReferenceDocuments":[{"name":"Date of Multiple Tumors","type":"Preferred Question Text","description":"Date of Multiple Tumors","url":null,"context":"PS-CC"},{"name":"NAACCR 12.1, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&tabid=133&mid=473","context":"PS-CC"},{"name":"Date of Multiple Tumors Description","type":"COMMENT","description":"See page 97 for date format.","url":null,"context":"PS-CC"},{"name":"NAACCR 16, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)","url":"https://www.naaccr.org/data-standards-data-dictionary/","context":"PS-CC"}],"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB3FE042-2E1B-9EEA-E040-BB89AD4338BE","latestVersionIndicator":"Yes","beginDate":"2010-06-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-08-24","modifiedBy":"HARTLEYG","dateModified":"2018-11-06","changeDescription":"08/24/2011 - tc - Updated with new display format as per V12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}